Craig A. Collard - 16 Nov 2023 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Craig Collard
Issuer symbol
HRTX
Transactions as of
16 Nov 2023
Net transactions value
+$137,970
Form type
4
Filing time
17 Nov 2023, 12:37:52 UTC
Previous filing
24 Aug 2023
Next filing
19 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Purchase $137,970 +150,000 +411% $0.9198 186,496 16 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The range of purchase prices paid was $0.8888 to $0.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased at each separate price.